Literature DB >> 6896895

Anterior pituitary, thyroid, parathyroid and adrenal responses to subtotal thyroidectomy in patients with Graves' disease.

T Mimura, N Hamada, Y Ban, H Mori, N Momotani, H Takami, Y Nishikawa, K Ito.   

Abstract

Changes in the serum levels of anterior pituitary, thyroid, parathyroid, and adrenal hormones following subtotal thyroidectomy in 31 patients with Graves' disease were investigated. In 14 patients, rapid ACTH tests were performed on the preoperative and the first, third, and seventh post-operative days. Remarkable differences were not seen with regard to the changes in anterior pituitary hormones or cortisol, compared to those seen during general surgery. As to the thyroid hormones, the serum level of triiodothyronine (T3) decreased markedly after surgery and fell to half that of the preoperative value on the first postoperative day. Thereafter, a low value of T3 was maintained during the early postoperative period. Unlike T3, the serum level of thyroxine (T4) decreased gradually until the 7th post-operative day. The levels of both epinephrine and norepinephrine increased transiently during surgery, but the serum level of norepinephrine increased again on the third postoperative day. In the postoperative period, almost half the number of patients showed an inadequate cortisol response to rapid ACTH tests. It is suggested that the unique responses, such as the rise in serum norepinephrine or an inadequate response of cortisol to ACTH, or hypocalcemia, after subtotal thyroidectomy in patients with Graves' disease is largely due to the rapid decrease of T3 in the hypothyroid state, as was noted during the postoperative period.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6896895     DOI: 10.1007/bf02469554

Source DB:  PubMed          Journal:  Jpn J Surg        ISSN: 0047-1909


  17 in total

1.  Determination of plasma catecholamines by high performance liquid chromatography with electrochemical detection: comparison with a radioenzymatic method.

Authors:  P Hjemdahl; M Daleskog; T Kahan
Journal:  Life Sci       Date:  1979-07-09       Impact factor: 5.037

2.  Mechanism of hypocalcaemia after thyroidectomy for thyrotoxicosis.

Authors:  W Michie; T Duncan; D W Hamer-Hodges; P D Bewsher; J M Stowers; C A Pegg; G Hems; A J Hedley
Journal:  Lancet       Date:  1971-03-13       Impact factor: 79.321

3.  Human prolactin and growth hormone release during surgery and other conditions of stress.

Authors:  G L Noel; H K Suh; J G Stone; A G Frantz
Journal:  J Clin Endocrinol Metab       Date:  1972-12       Impact factor: 5.958

4.  Acute effects of corticosteroids on thyroid activity in Graves' disease.

Authors:  D E Williams; I J Chopra; J Orgiazzi; D H Solomon
Journal:  J Clin Endocrinol Metab       Date:  1975-08       Impact factor: 5.958

5.  Decreased bone sensitivity of thyroidectomized rats to the calcaemic effect of 1,25-dihydroxycholecalciferol.

Authors:  H Pavlovitch; V Presle; S Balsan
Journal:  Acta Endocrinol (Copenh)       Date:  1977-04

6.  The effect of stressful diagnostic studies and surgery on anterior pituitary hormone release in man.

Authors:  J R Sowers; R P Raj; J M Hershman; H E Carlson; R W McCallum
Journal:  Acta Endocrinol (Copenh)       Date:  1977-09

7.  Effect of a single dose of dexamethasone on serum concentrations of thyroid hormones.

Authors:  W A Burr; D B Ramsden; R S Griffiths; E G Black; R Hoffenberg; H Meinhold; K W Wenzel
Journal:  Lancet       Date:  1976-07-10       Impact factor: 79.321

8.  The effect of glucocorticoids on thyrotropin secretion.

Authors:  J F Wilber; R D Utiger
Journal:  J Clin Invest       Date:  1969-11       Impact factor: 14.808

9.  Plasma corticotropin (ACTH), growth hormone (GH), and 11-OHCS (hydroxycorticosteroid) response during surgery.

Authors:  Y Ichikawa; M Kawagoe; M Nishikai; K Yoshida; M Homma
Journal:  J Lab Clin Med       Date:  1971-12

10.  The effect of dexamethasone on TSH and prolactin secretion after TRH stimulation.

Authors:  J H Dussault
Journal:  Can Med Assoc J       Date:  1974-12-07       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.